CLL: The Risk of Richter’s Transformation

CAR T-Cell Therapy for Richter’s TransformationПодробнее

Richter's Transformation Flash Session: CLL Society Global Virtual Patient & Caregiver Ed ForumПодробнее

Risk-factors for Richter’s transformationПодробнее

Phenotypes and molecular markers indicating elevated risk of RT in patients with CLLПодробнее

Finding Treatment Synergy in CLLПодробнее

Updates in CLL - 2023 Best of Hematology ConferenceПодробнее

Dr Nicholas Martinez discusses Richter's transformationПодробнее

Venetoclax Remissions in High Risk Chronic Lymphocytic Leukemia (CLL) - Dr. Philip Thompson ASH 2022Подробнее

Incidence of Richter’s Transformation in the Targeted Therapy Era - Dr. Paul Hampel ASH 2023Подробнее

Richter's Transformation after CAR-T Therapy in CLL (Chronic Lymphocytic Leukemia) - ASH 2021Подробнее

Predicting risk of CLL evolution to Richter’s syndromeПодробнее

U2' regimen with checkpoint inhibition in R/R CLL and Richter's transformationПодробнее

Update on CLL/SLL for Newly Diagnosed Patients | LRF WebinarsПодробнее

Richter's syndrome: clinical needs and treatment choicesПодробнее

Investigating the safety profile of enitociclib in patients with high-risk CLL & Richter's syndromeПодробнее

Novel Treatment Options in CLLПодробнее

CURE EDUCATED PATIENT: CLL WebinarПодробнее

ARI-0001 CAR-T therapy for R/R CLL and Richter’s syndromeПодробнее

Richter’s: Who will Get, What to Do?Подробнее

CLL: Treatment for BTKi ProgressorsПодробнее